Connect with us


LYPHE Group launches industry-first patient representative board

The board aims to ensure that patient’s voices are heard in the industry.



LYPHE group patient board
LYPHE is bringing patients to the table to explore how to improve the industry

In an industry first, LYPHE is bringing patients to the table to explore how to improve the patient experience across the organisation – and the wider industry.

Registration is now open for the company’s newly created Patient Representative Board, which will focus on patient concerns and issues in the medical cannabis industry.

It will be formed of independent patients from across the UK, Channel Islands and Isle of Man, as well as representatives from patient groups and charities. 

Since the rescheduling of medical cannabis in November 2018, LYPHE has been a key player in patient access, with the large majority of patients using its clinical services and dispensary to obtain medication. 

The teething pain and successes of the global medical cannabis industry have been well documented by commentators and patients alike.

Announcing the news, LYPHE said the industry’s first Patient Representative Board would ensure patient voices are heard.

Meetings will be held monthly, and feedback from the sessions will be used to further explore how to improve the patient experience. 

By working together, LYPHE hopes to bring about changes that will benefit the wider patient community, as well as shape the organisation’s future direction.

Discussing the initiative, LYPHE Group Managing Director Jonathan Nadler, said: “I’m delighted LYPHE is taking the initiative in working closely with patients. We want to build a stronger, more sustainable industry whilst continuing our journey for full patient access.

“The issues that impact our business, and the medical cannabis industry, ultimately impact our patients, which is why improving transparency with patient groups is vital.”

For more information on how to apply visit

Applicants or patient groups can register their interest by emailing their details along with reasons why they would like to join the Board via the contact form. 

Membership will be limited to a total of 12 representatives in addition to the two chairs. 

: A banner announcing collaborative work

Sarah Sinclair is a respected cannabis journalist writing on subjects related to science, medicine, research, health and wellness. She is managing editor of Cannabis Health, the UK’s leading title covering medical cannabis and CBD, and sister title and Psychedelic Health. Sarah has an NCTJ journalism qualification and an MA in Journalism from the University of Sunderland. Sarah has over six years experience working on newspapers, magazines and digital-first titles, the last two of which have been in the cannabis sector. She has also completed training through the Medical Cannabis Clinicians Society securing a certificate in Medical Cannabis Explained. She is a member of PLEA’s (Patient-Led Engagement for Access) advisory board, has hosted several webinars on cannabis and women's health and has moderated at industry events such as Cannabis Europa. Sarah Sinclair is the editor of Cannabis Health. Got a story? Email / Follow us on Twitter: @CannabisHNews / Instagram: @cannabishealthmag


Cannabis Health is a journalist-led news site. Any views expressed by interviewees or commentators do not reflect our own. All content on this site is intended for educational purposes, please seek professional medical advice if you are concerned about any of the issues raised.

Copyright © 2024 PP Intelligence Ltd.